Werewolf Therapeutics Inc News - HOWL | ADVFN

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Werewolf Therapeutics Inc (HOWL)
Werewolf Therapeutics Inc (HOWL) News

Werewolf Therapeutics Inc (HOWL)

2.86

0.17

(6.32%)

Closed July 15 4:00PM

Delayed by 15 minutes

2.86

0.00

( 0.00% )

Pre Market: 4:00AM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

– Additional monotherapy dose-escalation data from ongoing Phase 1/1b clinical trial of WTX-124 expected to be...

Werewolf Therapeutics to Present at the 2024 Leerink Partners Global Biopharma Conference

WATERTOWN, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or...

Werewolf Therapeutics Announces Upcoming Presentations at AACR Annual Meeting 2024

WATERTOWN, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Monksdream

Monksdream 2 months ago

Monksdream

Monksdream 6 months ago

HOWL new 52 week high

Pt3

Pt3 8 months ago

Yea your gap and trapped make me buy caud instead of this

TheFinalCD

TheFinalCD 8 months ago

HOWL todays algo patented Gap & Trap on Phase #1 news

TheFinalCD

TheFinalCD 8 months ago

Werewolf Therapeutics soars 52% premarket after presentsing preliminary monotherapy data from Phase 1/1b clinical trial establishing proof of mechanism for WTX-124$HOWL#AInvest #Ainvest_Wire #trade #source #wallstreet
View more: https://t.co/aTzfU7GqUS pic.twitter.com/rClSWzl2IS— AInvest Wire (@Ainvest_Wire) November 3, 2023

TheFinalCD

TheFinalCD 8 months ago

$howl flying https://finviz.com/quote.ashx?t=HOWL&ty=c&ta=1&p=d

https://dilutiontracker.com/app/search/HOWL

tw0122

tw0122 9 months ago

$3 + otw Halloween is here give it a HOWL

The Night Stalker

The Night Stalker 1 year ago

https://stockcharts.com/h-sc/ui?s=howl&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2

The Night Stalker

The Night Stalker 1 year ago

https://stockcharts.com/h-sc/ui?s=howl&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

The Night Stalker

The Night Stalker 1 year ago

surf1944

surf1944 1 year ago

https://stockcharts.com/h-sc/ui?s=howl&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/howl/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/howl/opinion

Mr. Zen

Mr. Zen 1 year ago

Watch list addition, this has the potential to run, just waiting for all the pieces of the puzzle to come together.

“These promising preclinical data add to a growing body of evidence demonstrating the potential of WTX-330 to drive targeted anti-tumor immune responses selectively in the tumor microenvironment (TME),” said Cynthia Seidel-Dugan, Ph.D., Chief Scientific Officer of Werewolf Therapeutics. “This morning, in our Third Quarter 2022 release, we announced that the FDA has granted clearance of the investigational new drug (IND) application for WTX-330. We are excited to advance WTX-330 into the clinic and to continue developing a pipeline of novel proinflammatory cytokine therapies that have the potential to change the lives of cancer patients.”

makinezmoney

makinezmoney 2 years ago

$HOWL: Hey thanks....... now 3.20.

Only getting better right ??

Enjoy those profits.

GO $HOWL

Makk1

Makk1 2 years ago

Good call here, looking very good

makinezmoney

makinezmoney 2 years ago

$HOWL: Looks like its turning...... now 2.25

Let see if volume pushes it up.

The setup is nice

GO $HOWL

bobbo5

bobbo5 2 years ago

I agree and it looks like share price has been moving up this past week

dia76ca

dia76ca 2 years ago

Very interesting company. I like it's chances.

Werewolf Therapeutics

Is $ Flt Rte Bd

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions